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TBlunt Thoracic Aortic Injuries: An Autopsy Study
Teixeira PG, Inaba K, Barmparas G, et. al. J Trauma 2011;70:197-202.
Conclusion: One third of patients with fatal blunt trauma have tho-
racic aortic injuries. The majority of deaths occur at the scene of the injury.
Summary: There have been recent paradigm shifts in the management
of blunt thoracic aortic trauma, including more widespread imaging using
CT scanning, aggressive blood pressure control of patients who reach the
hospital alive, delayed treatment of thoracic aortic injuries and more fre-
quent use of endovascular techniques for repair of blunt thoracic trauma.
These changes appear to have resulted in a decline in mortality from 22% to
13% for patients with thoracic aortic injuries who reach the hospital alive
(Demetriades D. J Trauma 2008;64:1415-8). Many patients with blunt
thoracic injury, however, cannot benefit from these advnces because they die
at the scene of the accident. To develop some sense of the magnitude of this
problem the authors analyzed autopsy findings in a series of blunt traumatic
fatalities. They reviewed autopsies for blunt trauma performed by the Los
Angeles County Coroner’s Office in 2005. Victims without thoracic aortic
trauma were compared with those with a traumatic thoracic aortic injury
with respect to patterns of associated injuries and differences in baseline
characteristics. During the study time there were 881 fatal victims of blunt
trauma received by the Los Angeles County Department of Coroner. Of
these 304 (35%) underwent a full autopsy and were included in the analysis
here. Average age was 43 21 years and 71% were men. The most common
mechanism of injury was a motor vehicle accident (50%) and the second
most common was a pedestrians struck by an auto (37%). 102 of the 304
victims (34%) had a thoracic aortic injury. The descending thoracic aorta was
the site of injury in 66%. Compared to patients without thoracic aortic
injuries those with thoracic aortic injuries were more likely to have a cardiac
injury (44% versus 25%; P .001), hemothorax (86% versus 56%; P .001),
rib fractures (86% versus 72%; P  .006), and intra-abdominal injury (74%
versus 49%; P  .001). Death at the scene was more likely if you had a
thoracic aortic injury (80% versus 63%; P  .002).
Comment: It is not surprising most patients with thoracic aortic injury
die at the accident scene.Motor vehicle accidents serve as the greatest source
of thoracic aortic injury. It is interesting that despite advances in automotive
and safety engineering the prevalence of blunt thoracic aortic injury inmotor
vehicle accidents does not seem to have been impacted by engineering
advances. The association of thoracic aortic injury with motor vehicle
accidents appears very similar to that, identified by Parmley, et. al. fifty years
ago (Parmley LF. Circulation 1958;17:1086-101). However, it is possible
engineering advances may have reduced the fatality rate of blunt aortic
thoracic trauma following motor vehicle trauma without affecting its prev-
alence.
Clopidogrel Versus Dipyridamole in Addition to Aspirin in Reducing
Embolization Detected with Ambulatory Transcranial Doppler: A
Randomized Trial
King A, Bath PM, Markus HS. Stroke 2011;42:650-5.
Conclusions: Dipyridamole and clopidogrel reduce cerebral emboli-
zation to a similar extent. Combinations of aspirin plus dipyridamole and
aspirin plus clopidogrel and are likely to have similar efficacies in the early
secondary prevention of stroke.
Summary: Patients with transient ischemia attack and stroke secondary
to large artery stenosis are at high risk for early recurrent stoke (Rothwell
PM, et al. Lancet Neurol 2006;5:323-31). Most data assessing the effects of
antiplatelet agents to prevent recurrent stroke are long term secondary
prevention trials and the combination of aspirin and Dipyridamole is more
effective than aspirin but equivalent to clopidogrel alone. (Sacco RL, et al.
N Engl J Med 2008;359:1238-51). The authors postulate best antiplatelet
therapy for early secondary stroke prevention may differ from that for long
term secondary prevention.Higher risks of bleedingmay be acceptable given
the high risk of early recurrent stoke following the initial event. Detection of
embolic signals, by ambulatory transcranial Doppler (TCD) was used as a
surrogate endpoint for clinical neurological events in the prediction of future
stoke with symptomatic carotid stenosis (Markus HS, et al. Circulation
2005;111:2233-40). This trial, termed The Ambulatory Dual Antiplatelet
(AMBDAP) study, was designed to determine whether dual antiplatelet
therapy with aspirin and clopidogrel was more effective than therapy with
aspirin and dipyridamole in preventing detection of embolic signals in
patients with acute symptomatic carotid stenosis. This study was based on a
new technique of ambulatory transcranial Doppler monitoring felt to be
more sensitive to embolic signals in patients with carotid stenosis (Mackin-
non AD, et al. Stroke 2005;36:1726-30).
c
4Patients with recent symptomatic carotid stenosis were recruited. Am-
ulatory transcranial Doppler and platelet aggregometry were performed at
aseline and at 48 hours. All patients were on aspirin, and were then
andomized to either receive dipyridamole or clopidogrel. TCD recordings
ere analyzed off line with interpreters masked to subject identity. There
ere 60 patients recruited to the study with 30 in each arm. There was no
ifference of the primary endpoint of change in embolic signal frequency
etween groups (P .36). In patients who had detectable embolic signals at
aseline there was no difference in reduction of embolic signal frequency
dipradamole (75.5; SD 17.7%) versus clopidogrel (77.5; SD 20.5%; P 
77)]. Platelet aggregation was not different between regimens at baseline.
t 48 hours, adenosine 5-diphosphate aggregation rate (but not collagen)
as lower with clopidogrel (P  .001).
Comment: In patients with acute extracranial cerebral vascular disease
oth clopidogrel and dipyridamole when added to aspirin therapy will
educe embolization rates detected by transcranial Doppler. The data has
mplications for design of future efficacy trials in that embolic signals
etected by TCD have been shown to a strong independent predictor of
troke rates in patients with extracranial symptomatic cerebral vascular
isease (King A et al. Stroke 2009;40:3711-7). The platelet aggregation
tudies confirmed the different mechanisms of action of clopidogrel and
ipyridamole in reducing platelet aggregation. Nevertheless the clinical end
oints with these two medications when added to aspirin would, based on
his data, be predicated to be the same with respect to secondary prevention
f acute symptomatic extracranial carotid artery disease. Phase III trials will
e needed to confirm clinical efficacy.
oes Carotid Intima-Media Thickness Regression Predict Reduction
f Cardiovascular Events? A Meta-Analysis of 41 Randomized Trials
ostanzo P, Perrone-Filardi P, Vassallo E. et al. J Am Coll Cardiol 2010;
6:2006-20.
Conclusion: Slowed progression or regression of carotid intima-media
hickness (IMT) induced by drug therapy does not translate into reduction
n clinical cardiovascular events.
Summary: Carotid intima-media thickness (IMT) predicts cardiovas-
ular events. IMT is therefore a potentially attractive biomarker as a thera-
eutic target in subjects at increased cardiovascular risk. IMT is considered a
anifestation of subclinical atherosclerosis. It has been included in the list of
rgan damaged conditions in European Hypertensive Guidelines and in the
uropean Prevention Guidelines. (Mancia G, et al. Eur Heart J 2007;28:
462-536, and Graham I, et al. Eur J Cardiovasc Prev Rehabil 2007;14
uppl 2:e1-40). IMT changes have been employed as surrogate clinical
nd-points in randomized clinical studies of lipid lowering agents, antihy-
ertensive agents, oral antidiabetic agents, and antioxidant drugs in subjects
t intermediate to high cardiovascular risk. Information verifying whether
hanges in IMT were associated with consistent changes in cardiovascular
isk profile would be relevant for interpretation of IMT variations and
urrogate clinical-end points and for identifying therapeutic targets for
ardiovascular therapies.
The author’s designed this meta-analysis to verify whether IMT regres-
ion is associated with reduced incidence of cardiovascular events. Cochrane
nd the Medline databases were searched for articles published until August
009. Included articles were randomized trials that assessed carotid IMT at
aseline and at follow-up and that also reported clinical end-points. A
eighted random-affects analysis was used to determine a relationship
etween mean and maximum IMT changes and outcome. Baseline patient
haracters, cardiovascular risk profile, IMT at baseline and follow up and
uality of the trials were also explored. Estimates and effects were calculated
ith a fixed-effects model, random-effects model or Peto method. There
ere 18,307 participants and 41 trials included in the analysis. There were
ignificant reductions in coronary heart disease, cerebral vascular disease
vents and all cause death induced by active treatments in the trial. However,
here was no significant relationship between IMT regression and coronary
eart disease events (tau, 0.91; P  .37), cerebral vascular events (tau,
0.32; P .75) and all cause death (tau,0.41; P .69). The association
etween IMT changes and clinical outcomes was not influenced by subject’s
aseline characters, cardiovascular risk profile, IMT at baseline, follow up or
uality of the trials.
Comment: The principle finding of the study is carotid IMT changes
o not correlate with changes inmajor cardiovascular events that are induced
y drug treatments in subjects at intermediate to high cardio vascular risk.
he US Preventative Task Force considers correlation of IMT changes with
linical events to be unproven (HelfandM, et al. Ann InternMed 2009;151:
96-507). There may be many unknown determinates of IMT that reduce
581
